BeiGene to Present at the Jefferies London Healthcare Conference
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, has announced its participation in the Jefferies London Healthcare Conference. The company will engage in a fireside chat on November 20, 2024, at 2:30 p.m. GMT. Investors can access the live webcast through BeiGene's investor relations websites, with a replay available for 90 days after the event.
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), un'azienda globale nel settore oncologico, ha annunciato la sua partecipazione alla Jefferies London Healthcare Conference. L'azienda parteciperà a una conversazione informale il 20 novembre 2024, alle 14:30 GMT. Gli investitori possono accedere alla diretta tramite i siti web delle relazioni con gli investitori di BeiGene, con una registrazione disponibile per 90 giorni dopo l'evento.
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), una empresa global de oncología, ha anunciado su participación en la Jefferies London Healthcare Conference. La empresa participará en una charla informal el 20 de noviembre de 2024, a las 14:30 GMT. Los inversores pueden acceder a la transmisión en vivo a través de los sitios web de relaciones con inversores de BeiGene, con una repetición disponible durante 90 días después del evento.
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), 글로벌 온콜로지 회사는 제퍼리즈 런던 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사는 2024년 11월 20일, 오후 2시 30분 GMT에 화상 대화에 참여할 예정입니다. 투자자들은 BeiGene의 투자자 관계 웹사이트를 통해 실시간 웹캐스트에 접근할 수 있으며, 이벤트 후 90일 동안 다시 볼 수 있는 기능이 제공됩니다.
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), une entreprise mondiale spécialisée en oncologie, a annoncé sa participation à la Jefferies London Healthcare Conference. La société participera à une conversation informelle le 20 novembre 2024, à 14h30 GMT. Les investisseurs peuvent accéder à la diffusion en direct via les sites de relations avec les investisseurs de BeiGene, avec une rediffusion disponible pendant 90 jours après l'événement.
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), ein globales Unternehmen im Bereich Onkologie, hat seine Teilnahme an der Jefferies London Healthcare Conference angekündigt. Das Unternehmen wird am 20. November 2024 um 14:30 Uhr GMT an einem informellen Gespräch teilnehmen. Investoren können den Live-Webcast über die Investor-Relations-Websites von BeiGene abrufen, mit einer Aufzeichnung, die 90 Tage nach der Veranstaltung verfügbar ist.
- None.
- None.
The live webcast of this event can be accessed from the investors section of BeiGene’s website at http://ir.beigene.com, https://hkexir.beigene.com/, https://sseir.beigene.com/. An archived replay will be available for 90 days following the event.
About BeiGene
BeiGene is a global oncology company that is discovering and developing innovative treatments that are more accessible and affordable to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 10,000 colleagues spans five continents. To learn more about BeiGene, please visit www.beigene.com and follow us on LinkedIn, X (formerly known as Twitter), Facebook and Instagram.
Forward-Looking Statements
This presentation may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding BeiGene's plans, commitments, aspirations and goals related to BeiGene’s medicines and drug candidates. Actual results may differ materially from those indicated in the forward-looking statements as a result of various important factors which are discussed in the section entitled “Risk Factors” in BeiGene’s most recent quarterly report on Form 10-Q filed with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20241106491351/en/
Investors:
Liza Heapes
+1 857-302-5663
ir@beigene.com
Media:
Kyle Blankenship
+1 667-351-5176
media@beigene.com
Source: BeiGene, Ltd.
FAQ
When is BeiGene (BGNE) presenting at the Jefferies London Healthcare Conference?
How long will the replay of BeiGene's (BGNE) Jefferies conference presentation be available?
Where can I watch BeiGene's (BGNE) Jefferies London Healthcare Conference presentation?
What stock exchanges is BeiGene (BGNE) listed on?
